September 17, 2014 — The industry’s first ultrasound real-time 3-D volume enhancement product from ContextVision has been paired with brand new image visualization capabilities. The resulting product, REALiCE, will deliver photo-realistic and improved diagnostic-quality 3-D ultrasound images.

The REALiCE software combines the GOPiCE adaptive 3-D/4-D volume enhancement product with brand new true-to-data rendering technology. This combination makes high-end visualization capabilities possible for many ultrasound manufacturers.

The software provides a new unique way of visualizing 3-D/4-D ultrasound images that improves image quality both in 3-D/4-D rendered images and in MPR views, enabling a clearer image and visualization of the fetus. The unique combination of 3-D volume enhancement in GOPiCE, scan conversion and rendering software results in high-quality images comparable to photos.

The ease of use of this visualization package allows for translucency adjustments, light source positioning, and skin softness and shading changes. The product delivers multiple views, including photographic view and versatile surface rendering view.

When integrated into ultrasound systems, REALiCE provides more accurate imaging to facilitate diagnosis and measurement. The adjustable views — including lighting source controls, translucency and tuning capabilities — will allow ultrasound manufacturers to meet the needs of a wide range of clinics and hospitals.

“Our photographic view offers further value to expecting parents. It also adds information to the clinician in fetal diagnosis,” sayid Anita Tollstadius, CEO of ContextVision. “We are confident that REALiCE will help ultrasound manufacturers make further advances within 3-D/4-D ultrasound.”

For more information: www.contextvision.com


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
Subscribe Now